DOCSLIB.ORG

Expanding Specialty Care

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expanding Specialty Care Milford Regional Medical Center Community Newsmagazine Winter/Spring 2019 Thoracic Surgery Expanding Discover how an emergency visit saved a patient from two Specialty Care potentially life-threatening Learn more about Milford medical conditions Regional’s growing list of Page 3 noted specialists and the difference they are making Robotic Hysterectomy in our patients’ lives! Find out how choosing the right physician resolved the discomfort and pain a patient had suffered from for years Page 7 Welcome Our New Specialists Get to know our new specialists in breast, thoracic and urology Pages 2, 5, 10 Next Generation in Robotic Surgery Learn more about the da Vinci Xi® and Milford Regional’s place as a regional leader in offering this advanced technology Page 9 Improve your health starting today! Sign up for lectures, exercise and healthy living programs Page 11 Reaching Higher Weight Loss Surgery I am excited about what the New Year brings to Milford Regional in 2019! Much work was done in 2018 to set the stage for new services, new growth and new Information Video physicians at Milford Regional; I am pleased to say that much was accomplished in all three Now Online! areas. NEW SERVICES - Milford Regional’s weight loss surgery program called Milford Regional has FreshStart had a banner year in 2018 with not one, but two expanded surgical quality-driven recognitions – starting with the program’s services with our recent elevated designation acquisition of the very to that of a latest in robotic-assisted Comprehensive Center surgery, the da Vinci by the Metabolic Xi®. The advanced and Bariatric Surgery technology offered Accreditation and through this next Edward J. Kelly, President & CEO Quality Improvement generation robotic Program. Achieving surgical system means our robotic surgeons can this new designation is based upon national quality standards perform more complex surgeries with fewer and smaller incisions. The da Vinci Xi takes minimally established to deliver safe, high-quality bariatric patient care. The Center for Weight Loss Surgery was also designated as invasive surgery to a whole new level, which means less ® post-operative pain and a shorter recovery for patients. a Blue Distinction Center for Bariatric Surgery by Blue Cross Feedback from our robotic surgeons and patients has Blue Shield of Massachusetts, which recognizes expertise been extremely positive. in delivering improved patient safety and better health GROWTH - Growth in our healthcare system is outcomes. What does this mean to our patients? The new coming soon to Franklin on Route 140 where a new designations mean the criteria has broadened for patients building will house both Milford Regional Physician who would like to have their weight loss surgery done at Group (MRPG) practices and Medical Center services. Milford Regional. The good news is more patients can now The Physician Group is bringing all of its Franklin access the FreshStart program at our Medical Center! Patients practices together under one roof – Franklin Family are already taking advantage of our expanded program. Practice, Franklin Primary Care, Franklin Pediatric & To make access to our FreshStart program even easier, Adolescent Care and Franklin Rheumatology. Urgent we have recently created an online video of our on-campus care is also being offered here, making it our fourth information session, which is the first step on your journey urgent care center in the region. The Medical Center to weight loss. The information session is required for access is providing diagnostic imaging (including radiology, to our program. Why? Because you need to understand the ultrasound and 3D mammography) and laboratory “how” and “why” of weight loss surgery before you commit services onsite. Area residents will benefit from the convenience of both physician offices and Medical to the journey. You now have a choice to either come to Center services in one close-to-reach location, as well as our campus to attend the information session, or watch the have easy access to urgent care. information session online. Both the online video and campus PHYSICIANS - Recognizing that Milford Regional’s options of the information session fulfill your first step in medical staff is the backbone of our healthcare system, accessing our FreshStart program. the Medical Center created a Physician Recruitment To register for our on-campus information session or access Committee in 2018 to bring the collective minds of our online video, go to our website at milfordregional.org and Milford Regional physicians, administrators and board click on Classes & Events; click on Weight Loss/Bariatric Surgery; members together to focus on recruitment efforts then click on FreshStart-On Campus Information Session, or within areas of greatest need. We are happy to report FreshStart-Online Information Session. recruiting success in both breast surgery and urology. Your journey to weight loss is just a couple clicks away! You’ll enjoy getting to know these specialists in this issue of Good Feelings. These exceptional physicians are already making a difference in the lives of our patients. This issue’s cover: FROM THE PRESIDENT & CEO The coming year will certainly have its challenges, Jim Laucis is happy to be active but I believe that Milford Regional’s healthcare system again after dealing with two serious is poised to not only meet, but exceed the expectations medical conditions back to back. we’ve set for ourselves. Our successes only inspire us to reach higher. As always, your thoughts and feedback are welcomed. Simply go to our website at milfordregional.org and click on Contact Us. We look forward to hearing from you! Sincerely, Ed Kelly, President & CEO Milford Regional Medical Center Good Feelings Thoracic Surgery A Win-Win Situation ince 2002, Milford Regional has collaborated with Brigham and Women’s Hospital to provide world-class thoracic surgery on our campus. The strength of the program is demonstrated by the expertise and skill of Sthe thoracic team assembled at the Medical Center. Milford Regional is very fortunate to welcome Drs. Brian to develop the physician assistant program at the outpatient Whang and Matthew Rochefort to the Brigham and Women’s surgery center at Patriot Place before returning to Milford in 2010. Thoracic Surgery practice now located on the second floor of the Dr. Whang looks at Dr. Rochefort and Physician Assistant LeSiege Hill Health Center. They are joined by Physician Assistant Chris as an indispensable team that works together to coordinate care LeSiege, a familiar face within the department since its inception. in surgery as well as patient management. “Our practice lends The team sees patients throughout the week, providing a itself to trying to help people without bringing them into Boston,” wide range of diagnostic and treatment services for benign he says. “It’s a great comfort knowing they can go nearby. We’re and malignant disorders of the lung, esophagus and stomach, very happy to be offering this here. It’s a win-win situation.” mediastinum (space between the lungs) and trachea. They offer You can schedule an appointment with Brigham and innovative and minimally invasive surgical treatments, as well Women’s Thoracic Surgery at Milford Regional by calling as traditional surgical procedures. As chief of thoracic surgery, (857) 307-5576. m Dr. Whang is excited about the opportunity to further grow the program at Milford Regional. “Working in a community Brigham and Women’s Thoracic Surgery team at hospital like this is nice as you tend to know all your colleagues Milford Regional. Pictured (left to right): Matthew Rochefort, MD; better – the radiology technicians, the staff in the operating Brian Wang, MD; and Chris LeSiege, PA-C. room, the nursing staff,” he notes. “We’re trying to make it a more robust program where we can handle more and do more complex surgeries. We’re looking forward to building on our strengths and taking it to the next level.” He explains that the team treats a variety of conditions including cancers, infectious problems, swallowing problems, stomach and esophagus issues, lung collapses and hiatal hernias. They also see a lot of lung nodules found incidentally on CT scans. “The mainstay of our practice, what we’re known for, is cancer,” states Dr. Whang. “The most common cancers are lung and esophageal cancer. Patients come to us with enough of a diagnosis to know they need us to take the next step. That often leads to additional imaging. It doesn’t always lead to surgery; sometimes it shouldn’t. We try to tailor our approach based upon the diagnosis, the patient’s condition and their own wishes.” Depending on the diagnosis, he says that other options might include radiation, chemotherapy, ablation therapy, freezing, immunotherapy or watchful waiting. Dr. Whang graduated from the State University of New York Downstate College of Medicine in 2001, and did residencies in general surgery at New York Medical College, Westchester Medical Center, and in cardiothoracic surgery at the Yale University School of Medicine, Yale-New Haven Hospital. Board-certified in thoracic surgery, he has been with Brigham and Women’s Hospital and taught surgery at Harvard Medical School since 2013. Dr. Rochefort graduated from the University of Miami Miller School of Medicine in 2009 and did a residency in general surgery and a research residency in surgical oncology at the University of California Los Angeles, David Geffen School of Medicine, as well as a residency in thoracic surgery
Load more

Recommended publications
  • Understanding Surgery a Guide for People with Cancer, Their Families and Friends
    Understanding Surgery A guide for people with cancer, their families and friends Treatment For information & support, call Understanding Surgery A guide for people with cancer, their families and friends First published April 2014. This edition April 2019. © Cancer Council Australia 2019. ISBN 978 1 925651 47 8 Understanding Surgery is reviewed approximately every three years. Check the publication date above to ensure this copy is up to date. Editor: Ruth Sheard. Designer: Eleonora Pelosi. Printer: SOS Print + Media Group. Acknowledgements This edition has been developed by Cancer Council NSW on behalf of all other state and territory Cancer Councils as part of a National Cancer Information Subcommittee initiative. We thank the reviewers of this booklet: Prof Andrew Spillane, Surgical Oncologist, Melanoma Institute of Australia, and Professor of Surgical Oncology, The University of Sydney Northern Clinical School, NSW; Lynne Hendrick, Consumer; Judy Holland, Physiotherapist, Calvary Mater Newcastle, NSW; Kara Hutchinson, Cancer Nurse Coordinator, St Vincent’s Hospital Melbourne, VIC; A/Prof Declan Murphy, Urologist and Director of Genitourinary Oncology, Peter MacCallum Cancer Centre, VIC; Caitriona Nienaber, 13 11 20 Consultant, Cancer Council WA; Prof Stephan Schug, Director of Pain Medicine, Royal Perth Hospital, and Chair of Anaesthesiology and Pain Medicine, The University of Western Australia Medical School, WA; Dr Emma Secomb, Specialist Surgeon, Hinterland Surgical Centre, QLD. We would like to thank the health professionals, consumers and editorial teams who have worked on previous editions of this title. This booklet is funded through the generosity of the people of Australia. Note to reader Always consult your doctor about matters that affect your health.
    [Show full text]
  • Complex General Surgical Oncology
    ACGME Program Requirements for Graduate Medical Education in Complex General Surgical Oncology ACGME-approved focused revision: February 3, 2020; effective July 1, 2020 Contents Introduction .............................................................................................................................. 3 Int.A. Preamble ................................................................................................................ 3 Int.B. Definition of Subspecialty ..................................................................................... 4 Int.C. Length of Educational Program ............................................................................ 4 I. Oversight ............................................................................................................................ 4 I.A. Sponsoring Institution............................................................................................ 4 I.B. Participating Sites .................................................................................................. 4 I.C. Recruitment ............................................................................................................. 6 I.D. Resources ............................................................................................................... 6 I.E. Other Learners and Other Care Providers ............................................................ 7 II. Personnel ...........................................................................................................................
    [Show full text]
  • Surgical Oncology 3 PGY3
    Stanford University General Surgery Residency Program Surgical Oncology 3 / Endocrine Surgery Rotation Goals and Objectives Rotation Director: Dana Lin, MD Description The Surgical Oncology 3 / Endocrine Surgery rotation offers an intensive experience in the surgical care of patients with endocrine diseases as well as breast cancer and melanoma. Goals The goal of the Surgical Oncology 3 / Endocrine Surgery rotation is to: Gain the knowledge and experience in the evaluation and management of patients with endocrine diseases, breast cancer, and melanoma. The primary goals for the R-3 resident: Develop knowledge and experience in the evaluation and management of patients with endocrine diseases, breast cancer, and melanoma. Acquire and refine procedural and operative skills required in the care of these patients. Direct the post-operative / in-patient care of the patients on the service. Objectives The Surgical Oncology 3/ Endocrine Surgery R-3 rotation has the following objectives: The resident has primary responsibility for the management of all patients admitted to or evaluated by the team in conjunction with the attending surgeon. The R-3 gains knowledge of surgical care through discussion with and teaching from the attending physicians in the inpatient and outpatient setting, attendance at the multidisciplinary endocrine tumor board conference, as well as independent reading. The resident gains operative skills through pre-operative reading and preparation and by direct intra-operative teaching and guidance from the faculty. Residents can expect frequent teaching from members of the team, both at the bedside and during formal and informal sessions. Feedback and teaching is individualized to the needs of the residents.
    [Show full text]
  • Tumor Registrar Vocabulary: the Composition of Medical Terms Book Three
    SEER Program Self InstructionalManual for Cancer Registrars Tumor Registrar Vocabulary: The Composition of Medical Terms Book Three Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISWRARS Book 3 - CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS Second Edition Originally Preparedfor the Louisiana Regional Medical Program Under the Direction of: C. Dennis Fink, Ph.D., Program Director, HumRRO Robert F. Ryan, M.D., Technical Advisor, Tulane University Revised by: SEER Program Cancer Statistics Branch, National Cancer Institute Editor-in-Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch, National Cancer Institute Assisted by Self-InstructionalManual Committee: Dr. Robert F. Ryan, EmeritusProfessor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred Weiss Ruth Navotny Mary A. Kruse LOs Angeles, California San Francisco, California Bethesda, Maryland BOOK 3 CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS TABLE OF CONTENTS BOOK 3: CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS Page Section A--Objectives and Content of Book 3 ................................... 1 Section B--Word Roots, Suffixes, and Prefixes ................................... 5 Section C--Common Symptomatic Suffixes ..................................... 31 Section D--Common Diagnostic Suffixes ....................................... 63 Section E--Cancer Registrar Vocabulary: Complaints
    [Show full text]
  • Gynecologic Oncology
    GYNECOLOGIC ONCOLOGY 2018 SAUDI FELLOWSHIP GYNECOLOGIC ONCOLOGY PROGRAM SAUDI FELLOWSHIP GYNECOLOGIC-ONCOLOGY CURRICULUM PREPARATION Curriculum Scientific Group DR. HANY SALEM DR. ISMAIL ALBADAWI DR. MOHAMMAD ALSHEHRI SUPERVISION Curriculum Specialists PROF. ZUBAIR AMIN DR. SAMI ALSHAMARRI REVIEW AND APPROVAL Scientific Council DR. HANY SALEM DR. ISMAIL ALBADAWI DR. MOHAMMAD ALSHEHRI DR. MOHAMMAD ADDAR DR. ABDULAZIZ AL-OBAID SAUDI FELLOWSHIP GYNE-ONCOLOGY CURRICULUM 1 COPYRIGHTS AND AMENDMENTS All rights reserved. © 2018 Saudi Commission for Health Specialties. This material may not be reproduced, displayed, modified, distributed, or used in any other manner without prior written permission of the Saudi Commission for Health Specialties, Riyadh, Kingdom of Saudi Arabia. Any amendment to this document shall be approved by the Specialty Scientific Council and the Executive Council of the commission and shall be considered effective from the date the updated electronic version of this curriculum was published on the commission Web site, unless a different implementation date has been mentioned. Correspondence: Saudi Commission for Health Specialties P.O. Box: 94656 Postal Code: 11614 Contact Center: 920019393 E-mail: [email protected] Website: www.scfhs.org.sa Formatted and Designed by: Manoj Thomas Varghese, CMT (SCFHS) 2 SAUDI FELLOWSHIP GYNE-ONCOLOGY CURRICULUM ACKNOWLEDGEMENTS The Gynecologic Oncology Fellowship Training team acknowledges the valuable contributions and feedback from the scientific committee members in the development of this program. We extend special appreciation and gratitude to all the members who have been pivotal in the completion of this booklet, especially the Scientific Council, Curriculum Group, and the Curriculum Specialists. We would also like to acknowledge that the CanMEDS framework is a copyright of the Royal College of Physicians and Surgeons of Canada, and many of the descriptions and competencies have been acquired from their resources.
    [Show full text]
  • Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer M
    Published OnlineFirst June 13, 2017; DOI: 10.1158/1078-0432.CCR-16-3224 Personalized Medicine and Imaging Clinical Cancer Research Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer M. Eileen Dolan1, Omar El Charif1, Heather E. Wheeler2, Eric R. Gamazon3, Shirin Ardeshir-Rouhani-Fard4, Patrick Monahan4, Darren R. Feldman5, Robert J. Hamilton6, David J. Vaughn7, Clair J. Beard8, Chunkit Fung9, Jeri Kim10, Sophie D. Fossa11, Daniel L Hertz12, Taisei Mushiroda13, Michiaki Kubo13, Lawrence H. Einhorn4, Nancy J. Cox3, and Lois B. Travis4; for the Platinum Study Group Abstract Purpose: Our purpose was to characterize the clinical influ- Results: Eight sensory items formed a subscale with good ences, genetic risk factors, and gene mechanisms contributing to internal consistency (Cronbach a ¼ 0.88). Variables signifi- persistent cisplatin-induced peripheral neuropathy (CisIPN) in cantly associated with CisIPN included age at diagnosis (OR À testicular cancer survivors (TCSs). per year, 1.06; P ¼ 2 Â 10 9), smoking (OR, 1.54; P ¼ 0.004), Experimental Design: TCS given cisplatin-based therapy com- excess drinking (OR, 1.83; P ¼ 0.007), and hypertension pleted the validated EORTC QLQ-CIPN20 questionnaire. An (OR, 1.61; P ¼ 0.03). CisIPN was correlated with lower À ordinal CisIPN phenotype was derived, and associations with self-reported health (OR, 0.56; P ¼ 2.6 Â 10 9) and weight age, smoking, excess drinking, hypertension, body mass index, gain adjusted for years since treatment (OR per Dkg/m2, diabetes, hypercholesterolemia, cumulative cisplatin dose, and 1.05; P ¼ 0.004). PrediXcan identified lower expres- self-reported health were examined for 680 TCS.
    [Show full text]
  • European Society of Gynaecological Oncology Quality Indicators for Surgical Treatment of Cervical Cancer
    Original research Int J Gynecol Cancer: first published as 10.1136/ijgc-2019-000878 on 3 January 2020. Downloaded from European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer David Cibula,1 François Planchamp,2 Daniela Fischerova,1 Christina Fotopoulou,3 Christhardt Kohler,4 Fabio Landoni,5 Patrice Mathevet,6 Raj Naik,7 Jordi Ponce,8 Francesco Raspagliesi,9 Alexandros Rodolakis,10 Karl Tamussino,11 Cagatay Taskiran,12 Ignace Vergote,13 Pauline Wimberger,14 Ane Gerda Zahl Eriksson,15 Denis Querleu2 For numbered affiliations see ABSTRACT as a component of comprehensive multi- disciplinary end of article. Background Optimizing and ensuring the quality of management has been shown to improve outcomes 3 4 surgical care is essential to improve the management and in patients with other types of malignancies. Imple- Correspondence to outcome of patients with cervical cancer. mentation of a quality improvement program helped Dr David Cibula, Department OBJECTIVE to reduce both morbidity and costs in other tumors of Obstetrics and Gynecology, University of Prague, 110 To develop a list of quality indicators for surgical treatment where surgical interventions are also high risk. Thus, 00 Staré Město, Czechia; d_ of cervical cancer that can be used to audit and improve it is likely that implementation of a quality manage- cibula@ yahoo. com clinical practice. ment program could improve survival of patients with Methods Quality indicators were developed using a cervical cancer. four- step evaluation process that included a systematic The aim of this project was to develop a list of Received 30 August 2019 literature search to identify potential quality indicators, Revised 17 October 2019 quality indicators for surgical treatment of cervical in- person meetings of an ad hoc group of international Accepted 22 October 2019 cancer that can be used to audit and improve clin- experts, an internal validation process, and external review by a large panel of European clinicians and patient ical practice in an easy and practicable way.
    [Show full text]
  • Standards for Oncology Registry Entry STORE 2018
    STandards for Oncology Registry Entry STORE 2018 Effective for Cases Diagnosed January 1, 2018 STORE STandards for Oncology Registry Entry Released 2018 (Incorporates all updates to Commission on Cancer, National Cancer Database Data standards since FORDS was revised in 2016) Effective for cases diagnosed January 1, 2018 See Appendix A for Updates since FORDS: Revised for 2016. Version 1.0 © 2018 AMERICAN COLLEGE OF SURGEONS All Rights Reserved STORE 2018 Table of Contents Table of Contents Table of Contents ......................................................................................................................... ii Foreword ..................................................................................................................................... 1 FROM “FORDS” TO “STORE” ..................................................................................................................... 1 Preface 2018 ................................................................................................................................ 2 Comorbidities and Complications ............................................................................................................. 2 Revisions to Staging Requirements ........................................................................................................... 2 Staging Data Items No Longer Required for Cases Diagnosed in 2018 and Later (Required for Cases Diagnosed 2017 and Earlier) ................................................................................................................
    [Show full text]
  • GUIDELINES for COMPETENCY BASED POSTGRADUATE TRAINING PROGRAMME for Mch in GYNAECOLOGICAL ONCOLOGY SUBJECT SPECIFIC OBJECTIVES
    GUIDELINES FOR COMPETENCY BASED POSTGRADUATE TRAINING PROGRAMME FOR MCh IN GYNAECOLOGICAL ONCOLOGY Preamble Gynaecological Cancers (Cancer cervix, cancer uterus, tubo-ovarian cancers, vaginal and vulval cancers) comprise 25-40% of patient workload in established Departments of Radiation Oncology, Medical Oncology and Surgical Oncology. Whereas specialities such as radiation oncology and medical oncology look after all cancers, there is lack of specialists interested or devoted to the field of “Gynaecological Oncology”. A subspecialist in Gynaecological Oncology is one who has undertaken formal training in field of Gynaecological oncology and acquires special expertise in the field of Gynaecological Oncology including broad based knowledge in related disciplines such as medical oncology, radiation oncology, gynaecological pathology and palliative management of patients suffering from gynaecological cancers. SUBJECT SPECIFIC OBJECTIVES The aims of Sub-specialisation in Gynaecological Oncology are: • To create a work force of specialists trained in the field of Gynaecological Oncology. • To improve practice, knowledge and research in the field of Gynaecological Oncology. • To improve standards of care for patients suffering from gynaecological cancers. • To encourage close understanding with disciplines such as Radiation Oncology and Medical Oncology involved in the care of women suffering from gynaecological cancer. • To encourage co-ordinated management of gynaecological cancers as a multidisciplinary approach. SUBJECT SPECIFIC COMPETENCIES By the end of the course, the student should have acquired knowledge (cognitive domain), professionalism (affective domain) and skills (psychomotor domain) as per details given below: 1 A. Cognitive domain (theoretical knowledge): The post graduate student should acquire knowledge in the following areas by the end of the training programme. Thorough understanding of: .
    [Show full text]
  • Cancer Surgeries in the Time of COVID-19: a Message from the SSO President and President-Elect
    Cancer Surgeries in the Time of COVID-19: A Message from the SSO President and President-Elect March 23, 2020 Dear SSO Members, In these unprecedented times, we are forced to consider triage and rationing of cancer surgery cases. Here are a few of the reasons: • the potential shortage of supplies, such as masks, gowns, gloves • the potential shortage of hospital personnel due to sickness, quarantine and duties at home • the potential shortage of hospital beds, ICU beds and ventilators • the desire to maximize social distancing amongst our patients, colleagues and staff. We have asked each of the SSO Disease Site Work Group Chairs and Vice Chairs to provide their recommendations for managing care in their specialties, assuming a 3- to 6-month delay in care. We have summarized their recommendations below. Numerous organizations are publishing in-depth guidelines, such as the NCCN, ACS, and ASCO, and we will provide links to those documents on the SSO Website. We have also instituted a COVID-19 community discussion page in My SSO Community for members to share what is happening in their institutions. In the next few days, SSO will produce a series of podcasts featuring discussions with experts, regarding their opinions and institutional practices. These podcasts will be available on SSO’s Website, iTunes, Sticher and other podcast platforms. Please watch your email and SSO’s Twitter and Facebook pages for details. The Annals of Surgical Oncology will be publishing an editorial on this topic soon. As each institution across the world is experiencing this pandemic at different levels, the timing of rationing care will vary and must be decided locally.
    [Show full text]
  • Current Approaches to Skin Cancer Management in Organ Transplant Recipients Meena K
    Current Approaches to Skin Cancer Management in Organ Transplant Recipients Meena K. Singh, MD,* and Jerry D. Brewer, MD† Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant. Semin Cutan Med Surg 30:35-47 © 2011 Elsevier Inc. All rights reserved. pproximately 225,000 people are living with organ violet B radiation induces direct DNA damage and indirectly Atransplants in the United States. Organ transplant recip- causes DNA damage through production of reactive oxygen ients (OTRs) are at increased risk for both cutaneous and species.6 UVR also promotes the development of skin cancer systemic malignancy. More than 1000 articles in the medical through cutaneous immunosuppression.7 literature discuss cancer in the setting of organ transplanta- The immunosuppressive regimen required for graft sur- tion, most of which focus on skin cancer. vival in OTRs may lead to an impaired immune surveillance Skin cancer is the most common human malignancy, with system, which may influence the development of skin can- approximately 3.5 million skin cancers diagnosed annually cers. Certain immunosuppressive agents may also promote in the United States.1 Nonmelanoma skin cancer (NMSC) is malignancy through direct carcinogenesis.8-10 Skin cancer in the most common type, with approximately 2.8 million basal the setting of organ transplantation is also influenced by hu- cell carcinomas and more than 700,000 squamous cell car- man papillomavirus carcinogenesis, cancer susceptibility cinomas (SCCs) diagnosed each year.
    [Show full text]
  • The Surgeon and the Patient with Cancer: the Development of Surgical Oncology
    Henry Ford Hospital Medical Journal Volume 30 Number 3 Article 11 9-1982 The Surgeon and the Patient with Cancer: The Development of Surgical Oncology Angelos A. Kambouris Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Kambouris, Angelos A. (1982) "The Surgeon and the Patient with Cancer: The Development of Surgical Oncology," Henry Ford Hospital Medical Journal : Vol. 30 : No. 3 , 156-159. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol30/iss3/11 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. Henry Ford Hosp Med J Vol 30, No 3,1982 Sjf]iii;^c:iciiil ,iAijr'III:icic The Surgeon and the Patient with Cancer: The Development of Surgical Oncology Angelos A. Kambouris, MD* The role ofthe surgeon in treating patients with cancer to become familiar with radiotherapy, its capabilities has changed over the past 30 years. For many years the and its side effects, in order to serve the best interests of surgeon was traditionally viewed as the key clinician in their patients. Cooperative teams of surgeons and radio­ treating cancer. This role was strengthened by the therapists were established, and as the results of their development of the concept of local-regional resections combined modalities became publicized, traditional for treating cancers ofthe breast (Halsted, 1894), rectum surgical approaches were modified.
    [Show full text]